Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
Phase 1
Recruiting
Conditions
Obesity
Overweight
Interventions
Drug: NNC0487-0111 (formulation D)
Drug: NNC0487-0111 (formulation C)
Subscribe
First Posted Date
2024-06-27
Last Posted Date
2024-07-03
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
120
Registration Number
NCT06478563
Locations
🇺🇸
Celerion, Lincoln, Lincoln, Nebraska, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy